MCRB earnings: a negative outcome, -32.5%

On May 8, 2024, Seres Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -32.5% in the window around the event. It had already run +58.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.